LMR Partners LLP Makes New $7.39 Million Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

LMR Partners LLP acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 78,711 shares of the company's stock, valued at approximately $7,387,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of GEHC. AMG National Trust Bank lifted its position in GE HealthCare Technologies by 35.0% during the third quarter. AMG National Trust Bank now owns 17,121 shares of the company's stock valued at $1,607,000 after purchasing an additional 4,439 shares during the last quarter. Aljian Capital Management LLC bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth about $847,000. Swiss National Bank lifted its holdings in shares of GE HealthCare Technologies by 0.5% in the 3rd quarter. Swiss National Bank now owns 1,287,187 shares of the company's stock worth $120,802,000 after acquiring an additional 6,500 shares during the last quarter. Thrivent Financial for Lutherans lifted its holdings in shares of GE HealthCare Technologies by 16.5% in the 3rd quarter. Thrivent Financial for Lutherans now owns 25,408 shares of the company's stock worth $2,385,000 after acquiring an additional 3,602 shares during the last quarter. Finally, Mutual of America Capital Management LLC lifted its holdings in shares of GE HealthCare Technologies by 5.0% in the 3rd quarter. Mutual of America Capital Management LLC now owns 56,349 shares of the company's stock worth $5,288,000 after acquiring an additional 2,696 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have commented on GEHC. BTIG Research raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. Evercore ISI upped their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 1st. Redburn Atlantic raised GE HealthCare Technologies to a "strong-buy" rating in a report on Thursday, August 1st. UBS Group cut GE HealthCare Technologies from a "neutral" rating to a "sell" rating and dropped their price target for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Finally, JPMorgan Chase & Co. started coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a "neutral" rating and a $90.00 target price on the stock. One analyst has rated the stock with a sell rating, five have issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and an average price target of $94.36.

GE HealthCare Technologies Stock Performance

Shares of GEHC traded down $0.20 during trading hours on Tuesday, reaching $82.52. 2,513,576 shares of the company's stock traded hands, compared to its average volume of 3,045,142. The business's fifty day simple moving average is $88.65 and its two-hundred day simple moving average is $83.55. The firm has a market capitalization of $37.70 billion, a price-to-earnings ratio of 22.73, a P/E/G ratio of 2.93 and a beta of 1.24. GE HealthCare Technologies Inc. has a twelve month low of $66.39 and a twelve month high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. GE HealthCare Technologies's revenue was up .9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.99 earnings per share. Analysts predict that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.03 dividend. The ex-dividend date was Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. GE HealthCare Technologies's dividend payout ratio is currently 3.30%.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the firm's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.